Genprex, Inc. SEC filings GNPX
Genprex, Inc. has 491 filings in SEC EDGAR's recent list, going back to Dec 26, 2013. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Other events
|
Oct 21, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Other events
|
Aug 18, 2026 | Aug 18, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 5, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Jul 30, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 14, 2026 | Jul 13, 2026 |
| S-8 | Employee stock plan registration | Jun 26, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 12, 2026 | Jun 10, 2026 |
| S-3 | Shelf registration | Jun 5, 2026 | — |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Other events
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 30, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Other events
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 21, 2026 | Apr 21, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Apr 15, 2026 | Apr 14, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Mar 18, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Other events
|
Feb 23, 2026 | Feb 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 10, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Other events
|
Jan 9, 2026 | Jan 7, 2026 |
| S-8 | Employee stock plan registration | Jan 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 23, 2025 |
| EFFECT | Filing | Dec 12, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| CORRESP | Letter to the SEC | Dec 10, 2025 | — |
| S-1/A | Amended registration statement | Nov 26, 2025 | — |
| 8-K |
Current report
Listing notice
|
Nov 26, 2025 | Nov 25, 2025 |
| S-1 | Registration statement | Nov 21, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 21, 2025 | Nov 21, 2025 |
| 424B5 | Prospectus supplement | Nov 21, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 19, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| S-8 | Employee stock plan registration | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 424B5 | Prospectus supplement | Nov 10, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 4, 2025 | Nov 4, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 3, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 29, 2025 | Oct 28, 2025 |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 24, 2025 | Oct 23, 2025 |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Other events
|
Oct 21, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 17, 2025 | Oct 13, 2025 |
| EFFECT | Filing | Sep 16, 2025 | — |
| 424B3 | Prospectus | Sep 16, 2025 | — |
| CORRESP | Letter to the SEC | Sep 12, 2025 | — |
| S-1 | Registration statement | Sep 12, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| DRS | Filing | Sep 5, 2025 | — |
| 8-K |
Current report
Listing notice
|
Aug 20, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 15, 2025 | Aug 15, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| RW | Form rw | Aug 5, 2025 | — |
| DEFA14A | Additional proxy material | Aug 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2025 | Aug 4, 2025 |
| ARS | Annual report to shareholders | Jul 16, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jul 16, 2025 | Aug 15, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 3, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| EFFECT | Filing | Jun 17, 2025 | — |
| 424B3 | Prospectus | Jun 17, 2025 | — |
| CORRESP | Letter to the SEC | Jun 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2025 | — |
| S-1 | Registration statement | Jun 11, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Listing notice
|
Jun 9, 2025 | Jun 6, 2025 |
| S-1 | Registration statement | May 14, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| DRS | Filing | Apr 24, 2025 | — |
| NT 10-K | Form nt 10-k | Apr 1, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Apr 1, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Regulation FD disclosure, Other events
|
Feb 18, 2025 | Feb 17, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 12, 2025 | Feb 7, 2025 |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 23, 2025 | Jan 23, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 424B5 | Prospectus supplement | Dec 20, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Other events
|
Nov 20, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 19, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 424B5 | Prospectus supplement | Nov 8, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 5, 2024 | Nov 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 24, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 3, 2024 | — |
| 8-K |
Current report
Listing notice
|
Sep 26, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Other events
|
Sep 4, 2024 | Sep 4, 2024 |
| 424B5 | Prospectus supplement | Aug 16, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 13, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jun 24, 2024 | Jun 18, 2024 |
| 424B5 | Prospectus supplement | May 20, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change
|
May 9, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 18, 2024 |
| S-8 | Employee stock plan registration | Apr 17, 2024 | — |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 20, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Other events
|
Mar 6, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Other events
|
Feb 26, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 18, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 18, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 5, 2024 | Feb 4, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2024 | Jan 30, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jan 31, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 18, 2023 | Dec 14, 2023 |
| 424B5 | Prospectus supplement | Dec 13, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 13, 2023 | Dec 12, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| DEFA14A | Additional proxy material | Nov 3, 2023 | — |
| DEF 14A | Proxy statement | Nov 3, 2023 | Dec 14, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 23, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Auditor change
|
Sep 25, 2023 | Sep 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 1, 2023 | Aug 30, 2023 |
| 8-K/A |
Amended current report
Auditor change
|
Aug 21, 2023 | Jul 10, 2023 |
| 10-Q | Quarterly report | Aug 21, 2023 | Jun 30, 2023 |
| NT 10-Q | Form nt 10-q | Aug 15, 2023 | Jun 30, 2023 |
| SC 13G | Ownership over 5% (passive) | Jul 24, 2023 | — |
| 424B5 | Prospectus supplement | Jul 20, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 19, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 18, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Auditor change
|
Jul 14, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jun 29, 2023 | Jun 27, 2023 |
| 4 | Insider transaction | Jun 29, 2023 | Jun 27, 2023 |
| 4 | Insider transaction | Jun 29, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 27, 2023 | Jun 27, 2023 |
| EFFECT | Filing | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| 8-K |
Current report
Other events
|
May 26, 2023 | May 25, 2023 |
| 10-Q | Quarterly report | May 22, 2023 | Mar 31, 2023 |
| NT 10-Q | Form nt 10-q | May 16, 2023 | Mar 31, 2023 |
| 8-K/A |
Amended current report
Auditor change
|
May 12, 2023 | Mar 3, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 27, 2023 |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| 8-K/A |
Amended current report
Auditor change
|
Apr 27, 2023 | Mar 3, 2023 |
| 4 | Insider transaction | Apr 24, 2023 | Apr 21, 2023 |
| 4 | Insider transaction | Apr 24, 2023 | Apr 21, 2023 |
| S-3 | Shelf registration | Apr 21, 2023 | — |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Auditor change
|
Mar 6, 2023 | Mar 3, 2023 |
| 424B5 | Prospectus supplement | Feb 28, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 27, 2023 | Feb 26, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 18, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 18, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 18, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 18, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 18, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GNPX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1595248
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.